CalAsia Pharmaceuticals Receives $600,000 SBIR Grant

CalAsia Pharmaceuticals, founded by SDEE member Sridhar Prasad  was awarded a $600,000 NIH Phase I SBIR grant to develop novel antiviral agents for the treatment of Dengue (DENV) fever and West Nile Virus (WNV) infection. 

Approximately, 100 million DENV infections each year result in about 25,000 deaths.  During 2012, United States witnessed a sudden surge in WNV infections, with more than 5,000 cases in 48 states and 228 deaths.  CalAsia and its collaborator have identified compounds with development potential for potent, safe, and low-cost medications to treat DENV and WNV infection.

Attend SDEE Events Donate | Sponsor SDEE Become a Member

Connect with SDEE

Sign Up for SDEE Newsletter


Morrison Foerster Alexandria


Takeda San Diego BDO logo


Barney and Barney Longfellow Pineapple.gif

SDEE is a nonprofit 501(c)(3) organization founded by local San Diego entrepreneurs
in order to provide a voice for the early stage start-up, to support new entrepreneurs and their companies,
and to sponsor networking and educational events
to help develop the skills necessary to bring funding, business, and jobs to the San Diego area.

© 2015 San Diego Entrepreneurs Exchange. All Rights Reserved